Accessibility navigation


Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice

Beckhove, P., Oberschmidt, O., Hanauske, A.R., Pampillon, C., Schirrmacher, V., Sweeney, N.J., Strohfeldt, K. and Tacke, M. (2007) Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice. Anti-cancer Drugs, 18 (3). pp. 311-316. ISSN 0959-4973

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1097/CAD.0b013e328010a6f7

Abstract/Summary

Bis-[(p-methoxybenzyl)cyclopentadienyl] titanium dichloride, better known as Titanocene Y, is a newly synthesized transition metal-based anticancer drug. We studied the antitumor activity of Titanocene Y with concentrations of 2.1, 21 and 210 mu mol/l against a freshly explanted human breast cancer, using an in-vitro soft agar cloning system. The sensitivity against Titanocene Y was highly remarkable in the breast cancer tumor in the full concentration range. Titanocene Y showed cell death induction at 2.1 mu mol/l, well comparable to cisplatin, given at a concentration of 1.0 mu mol/l. A further preclinical development of Titanocene Y was warranted and therefore an MCF-7 human breast cancer xenograft nonobese diabetic/severe combined immunodeficient mouse model was used. Titanocene Y was given for 21 days at 30 mg/kg/ day (75% of the maximum tolerable dose of Titanocene Y), which resulted in the reduction of the tumor volume to around one-third, whereas no mouse was lost because of the surprisingly low toxicity of Titanocene Y.

Item Type:Article
Refereed:Yes
Divisions:Faculty of Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy
ID Code:13790
Uncontrolled Keywords:anticancer drug, breast cancer, cisplatin, human tumor cloning assay, hydridolithiation, MCF-7 xenograft, super hydride, titanocene , SUBSTITUTED ANSA-TITANOCENE, POTENTIAL ANTICANCER DRUGS, TITANIUM DICHLORIDE, ORGANIC-CHEMISTRY, FULVENES, METALLOCENES, COMPLEXES, AGENTS, CISPLATIN, CANCER

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation